{"text":"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonism of NECA-induced stimulation of adenylate cyclase activity in human platelet membranes at A2-adenosine receptor; value ranges from 21-30","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement [3H]-CGS-21,680 from Adenosine A2A receptor in rat striatal membrane.","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Effect of intravenous infusion on diastolic pressure in Anesthetized cats at a dose of 1.50 mg\/kg at 10 min","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity against dopamine receptor D1","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Minimum inhibitory concentration required for antibacterial activity against Escherichia coli 10418","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Relative binding affinity (RBA) for estrogen receptor at 0C","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Irreversible antagonism to morphine was evaluated after 30 min incubation of GPI with the compound at 1000 nM conc.","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against a human colon cancer cell line (HCT116 cells) was reported","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In vitro inhibitory activity against HMG CoA reductase","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Potency relative to progesterone in reducing the difference in reversal of DOX accumulation between MDA-435\/LCC6 and MDA-435\/LCC6-MDRI cells","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiprotozoal activity (functional assay) using Mauden-Downing bovine kidney (MDBK) host cells infected with Eimeria tenella","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Uterotrophic activity in immature mouse","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Concentration that inhibited 50% of binding of 125 I -PYY ligand to human Neuropeptide Y receptor type 5","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of binding of [3H]diprenorphine to cloned human Opioid receptor kappa 1 expressed in CHO cell membrane","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for the ability to displace mu-receptor specific radioligand [3H]DAGO","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In vitro inhibitory activity against human PANC-1 pancreatic tumor; Active","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 (CDC\/Sierra Leone I); Not active","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of [3H]PGE-2 from human Prostaglandin E receptor EP3 expressed in CHO-KI cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Opioid agonist activity by measuring the analgesia produced after 10 mg\/kg administration in rats; none","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Amount of milk ingested after the 120 min methamphetamine-challenges, produced by the compound at 0.312 mg\/kg in fasted rats","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Percent decrease in angiotensin I pressor response was measured in rat, administered intravenously at dose 0.010 mg\/kg","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Percentage of animals emitting 50 presses on the LSD appropriate lever during the test period in rat at 0.02 mg\/kg(0.046 uM\/kg)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"In vitro minimum inhibitory concentration against Staphylococcus epidermis ATCC 12228","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"In vitro inhibitory activity against thrombin; ND= not determined","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"The compound was tested for relative binding affinity against calf uterine receptor using [3H]estradiol as radioligand","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Compound was evaluated for the binding constant for association with nicotinic acetylcholine receptor (nAChR)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity towards human 5-hydroxytryptamine receptor 6 expressed in HeLa cells using the radioligand [3H]LSD","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against HEK293 cells relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of 3H]RX821002 from rat cortex adrenergic alpha-2 receptor","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]SR141716A from human CB1 receptor expressed in CHO cells at 10 uM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus double stranded DNA","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]oxytocin from human oxytocin receptor expressed in CHO cells at 1000 nM","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of Kcat to Km for HIV1 reverse transcriptase assessed as nucleotide excision activity in presence of 0.5 uM dCTP","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]Ro-154513 from benzodiazepine binding site of GABAA alpha-4-beta-2-gamma-2 receptor expressed in HEK293T cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'ACGCGT3' sequence of cognate DNA assessed as change in melting temperature by thermal denaturation method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to HTG21 DNA assessed as induction of guanine-rich DNA to G-quadruplex structure formation","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to single stranded AT-rich oligonucleotide assessed as retardation of oligonucleotide movement by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Stabilization of synthetic duplex DNA assessed as melting temperature by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 0.3 uM under K+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to G-quadruplex F21T DNA assessed as change in melting temperature at 0.6 uM under K+ ionic conditions by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric G-quadruplex F21T DNA assessed as change in melting temperature at 2.0 uM by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]NMS from human cloned muscarinic M5 receptor expressed in insect Sf9 cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Staphylococcus epidermidis NCIMB 8853 by microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to Plasmodium falciparum spermidine synthase by saturation transfer difference-NMR experiment","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human Hs 633T cells at 2 uM assessed as fraction of viable cells after 72 hrs relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA by fluorescence spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to bone assessed as drug level bound to cattle bone meal powder by fluorescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA at 80 uM by spectrophotometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human MCF7 cells by SRB assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as relative fluorescence intensity by fluorescence emission spectra analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of LPS and INF-gamma-induced iNOS mRNA expression in mouse RAW264.7 cells by RT-PCR analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at human CB1 receptor expressed in SF9 cells assessed as inhibition of CP-55940-stimulated GTP binding","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of F-BakBH3 from Bfl-1 by fluorescence polarization assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of ALK7 expressed in baculovirus\/Sf9 cells assessed as inhibition of receptor autophosphorylation at 0.1 uM after 3 hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of Torpedo california AChE at 25 uM by Ellman's method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of 26S proteasome beta 2 in human HEK293 cell lysate assessed as residual activity at 0.03 uM after 1 hr","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of cKIT","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antilipolytic activity in po dosed rat assessed as reduction plasma free fatty acids levels","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H](+)-pentazocine from sigma1 opioid receptor from guinea pig brain cortex at 1 uM after 150 mins by scintillation counting","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to GGTase-1 F52Y\/Y126T mutant assessed as prenylation of RhoA GTPase by Western blot method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to (CAG-CAG) trinucleotide repeats at 120 uM by ESI-TOF mass spectroscopy","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of IC50 for inhibition of HIV1 HXB2 gp120-mediated viral infusion into HEK293 cells in presence of 45 mg\/ml human serum albumin to IC50 for inhibition of HIV1 HXB2 gp120-mediated viral infusion into HEK293 cells in absence of 45 mg\/ml human serum albumin","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimicrobial activity against Legionella pneumophila ATCC 33153 infected in THP1 cells after 48hrs","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antibacterial activity against Salmonella enterica serovar Enteritidis assessed as percent susceptible isolates by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antimicrobial activity against Enterococcus faecalis ATCC 29212 by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antibacterial activity against 1 x 10'4 CFU Streptococcus pneumoniae ATCC 6305 after 18 hrs by CLSI 2-fold agar dilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antiviral activity against Hepatitis C virus subtype 1b expressing NS3 R155K mutant infected in HuH7 cells after 48 hrs by by luciferase reporter assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antimicrobial activity against 5-fluorocytosine resistant Candida glabrata isolate TE34-78 harboring Fcr1 L136R mutant assessed as lowest concentration inhibiting growth >=80% by broth microdilution method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to SAM1 riboswitch aptamer assessed as change in heat at 0.5 mM at pH 7.5 by Isothermal titration calorimetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to supercoiled pRYG DNA at 0.1 uM after 10 mins by by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding constant for DRAK1 kinase domain","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-GCGATATATGCG-3' DNA sequence in PBS buffer of pH 7.4 assessed as increase in melting temperature by by UV-VIS spectrophotometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to 5'-GCGATATATGCG-3' DNA sequence in PBS buffer of pH 7.4 assessed as change in melting temperature by by UV-VIS spectrophotometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to STAT3 G-quadruplex in 3'-flanking region 5'-GGGCTGGGGATGGGGAGGGGG-3' assessed as melting temperature at 40 uM by UV-Vis spectrophotometry (Rvb = 58 degC)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of ethidium bromide from salmon sperm DNA at 25 uM by fluorescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human recombinant RON at 0.5 uM by radiometric filter-binding assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to telomeric Duplex DNA 5'-d(CGTTCAGAGCCGOxodGTTACGTCCTTCAT) 3'-d(CGAAGTCTGGCCAATGCAGGAAGTA) at 1 to 10 uM by CD titration method in presence of 100 mM of KCl","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex assessed as fluorescence quenching at 10 uM after 3 mins by fluorescence titration method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human telomeric AGGG(TTAGGG)3 quadruplex assessed as melting temperature at 1:1 compound to DNA ratio at pH 7 by UV-visible spectrophotometer analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA assessed as bathochromic shift by UV-spectroscopic analysis with compound pretreatment with CYP450","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to chicken blood dsDNA assessed as shift in Ep\/mv at 1 x 10 '-3 M at pH 4.7 by cyclic voltammetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to chicken blood dsDNA assessed as shift in Ep\/mv at 1 x 10 '-3 M at pH 7.4 by cyclic voltammetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity at 5-HT2A receptor by radioligand displacement assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of ABL","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to polyd(GC)2 DNA by UV titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA in presence of citrate-phosphate buffer at pH 7 by spectrophotometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as melting temperature","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of GPIbalpha-vWF binding assessed as inhibition of ristocetin-induced platelet agglutination at 100 uM after 2 mins by static agglutination assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as partial clear inhibition zone at 50 uL of 2 mM solution of compound in 1:9 DMSO\/MeOH after 24 hrs by agar diffusion method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antimigraine activity in marmosets assessed as inhibition of CGRP-induced increase in facial blood flow at 1 mg\/kg, sc administered 30 mins post CGRP-challenge measured up to 105 mins by laser doppler flowmetry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antitumor activity against human A549 cells xenografted in nu\/nu mouse assessed as inhibition of tumor volume at 3 mg\/kg, ip administered three times a week for 3 weeks","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of FGFR2 by TR-FRET analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Fungicidal activity against Trichoderma viride CECT 2423 at 0.2 mg\/disk after 48 hrs by agar diffusion assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Ratio of MH IC50 to compound IC50 for AChE in Musca domestica (house fly) brain","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antihyperlipidemic activity in high fat-high cholesterol fed New Zealand Oryctolagus cuniculus (rabbit) assessed as total cholesterol level in blood at 10 mg\/kg, po for 40 days (Rvb = 8.74 +\/- 0.53 mmol\/l)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antidiabetic activity against STZ-induced diabetic Rattus norvegicus Wistar albino (rat) assessed as change in hemoglobin at 20 mg\/kg, po administered via intragastric tube for 45 days (Rvb = 8.5 +\/-0.9 mg\/dl)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of Nitrosomonas europaea ATCC 25978-mediated nitrification activity assessed as nitrite nitrogen formation at 0.5 mg\/kg after 7 to 10 days by Griess-Ilosvay method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Bactericidal activity against Salmonella typhi after 72 hrs by serial subcultivation method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Binding affinity to JAK1 (unknown origin) at 10 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cell cycle arrest in human Bel7402 cells assessed as accumulation at S phase at 0.15 uM after 48 hrs by propidium iodide staining-based FACS analysis (Rvb = 39.17 %)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells up to 0.1 mM after 2 hrs by scintillation counting analysis","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Trypanocidal activity against epimastigote stage of Trypanosoma cruzi Y at 5 ug\/mL after 72 hrs by MTT assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Inhibition of His-thrombin-TEV-tagged cIAP1 BIR3 domain (260 to 352) (unknown origin) after 1 hr by TR-FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as hypochromicity at 20 uM after 2 hrs by UV-Vis absorption titration analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to N-terminal domain of human Hsp90alpha by FAXS competitive binding assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction of parasitemia at 10 mg\/kg, po qd administered 3 days by flow cytometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human recombinant TLR4 at >320 uM by SPR method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Competitive binding affinity to GLO-1 in HEK293T cell lysate at 50 uM after overnight incubation followed by UV-irradiation for 1 hr by pull-down assay in presence of N-(4-(4-(5-fluoro-4-(2-(methylsulfonamido)phenylamino)pyrimidin-2-ylamino)benzoyl)phenyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in p53 knock down human HCT116 cells assessed as PARP cleavage at 1 uM after 24 hrs by immunoblotting analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of BACE1 (unknown origin) incubated for 1 hr prior to testing measured after 1 hr by FRET assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]AF-DX384 from human recombinant M2 receptor expressed in CHO cells","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antagonist activity at 5-HT2A receptor (unknown origin) at 10 mM by functional assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cell cycle arrest in human MCF7 cells assessed as accumulation at G0 phase at 2 uM after 48 hrs by FACS analysis (Rvb = 1.83 +\/- 0.28%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to KAT2A in human HUT78 cells incubated for 45 mins by mass spectrometry based bromosphere chemoproteomic assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human MGC803 cells assessed as compact and condensed chromatin at 10 uM after 48 hrs using Hoechst 33258 staining by fluorescence microscopic analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antileishmanial activity against Leishmania donovani MHOM\/IN\/80\/Dd8 expressing luciferase reporter gene infected in mouse J-774A1 cells assessed as inhibition of amastigote stage formation incubated for 72 hrs by luminometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 after 18 to 24 hrs by spectrophotometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Displacement of [3H]-ketanserin from human 5-HT2A receptor expressed in HEK293 cells incubated for 1 hr","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human K562 cells assessed as downregulation of Bcl-2 protein expression by Western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human K562 cells assessed as up-regulation of Bax protein expression by Western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]CP55940 from CB1 receptor in Wistar rat brain incubated for 60 mins by radioactive filter binding assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of human liver cathepsin B using Cbz-Arg-Arg-pNA as substrate at pH 6 incubated for 30 mins measured for 20 mins by photometrical analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Effect on ITGB2 gene expression in serum-starved HUVEC after 6 hrs by microarray analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Bactericidal activity against Mycobacterium smegmatis MC2 155 assessed as log reduction in bacterial colonies at 4 times MIC measured after 24 hrs by time-kill assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Stabilization of BRAF in human K562 cells after 1 hr by thermal shift assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]NVP-QAW039 from human DP2 receptor expressed in CHO cell membranes assessed as association rate constant by TopCount scintillation assay","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [125I]-[Nle75, Tyr77] Pyr1-apelin-13 from YFP-tagged human APJ receptor expressed in HEK293 cell membranes after 1 hr by gamma-counting method","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Ratio of Kinact to Ki for S-adenosyl-L-homocysteine hydrolase (unknown origin)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of MET (cMet) (unknown origin) at 1 uM relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of FMS (unknown origin) assessed as remaining activity at 7.81 x 10'-8 M after 120 mins in presence of 33P-ATP (Rvb = 102.91%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length ERK2 (M1 to S360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human full length PHKG1 (M1 to Y387 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length ULK2 (M1 to S301 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of apoptosis in human MDA-MB-231 cells assessed as early apoptotic cells at 10 uM after 72 hrs by annexin-V\/propidium iodide double staining based flow cytometry (Rvb = 0.02%)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity in human NCI-H446 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of recombinant full-length human SRC assessed as residual activity at 10 uM using Cdc2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length EPHA3 (D604 to K889 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to wild-type human partial length LYN (C219 to Q511 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against carbapenem-resistant Escherichia coli BAA-2469 clinical isolates after 18 to 20 hrs in aerobic condition by CLSI-based broth microdilution assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Modulation of M2 polarization in mouse RAW264.7 cells assessed as up regulation of PPARGC1A mRNA expression at 300 nM measured after 24 hrs by qRT-PCR analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antiinflammatory activity in Wistar albino rat assessed as reduction in carrageenan-induced paw volume at 12.5 mg\/kg, ip measured after 1 hr by plethysmometric method (Rvb = 1.43 +\/- 0.19 ml)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of morphological changes in human HeLa cells assessed as swollen cells at IC50 after 24 hrs by phase contrast microscopic analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human partial length PIK3CA E545A mutant (R108 to N1068 residues) expressed in mammalian expression system measured after 1 hr by kinomescan method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]CP 55940 from human recombinant CB1 receptor at 10 uM after 120 mins by scintillation counting analysis relative to control","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of YqiG protein expression in Bacillus subtilis 168 at 2.3 uM incubated for 15 mins by 35S-methionine pulse labeling based 2D-PAGE analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Covalent binding affinity to human GRK5 assessed as covalent bond formation with Cys474 by intact protein mass spectrometry","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to zanamivir\/oseltamivir resistant recombinant Influenza A virus (A\/Moscow\/10\/99(H3N2)) Neuraminidase N2 E119V\/I222L double mutant expressed in baculovirus infected insect cells at 100 to 1000 nM measured up to 160 sec by surface plasmon resonance analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Inhibition of P-gp mediated efflux in adriamycin-resistant human HepG2 cells assessed as intracellular rhodamine-123 accumulation at 2 uM incubated in dark condition for 90 mins by flow cytometry relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Cytotoxicity against human A549 cells assessed as cell survival up to 10 uM incubated for 24 hrs by CCK8 assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus duplex DNA assessed as induction of hyperchromic shift at 257 nanometer at 50 uM in pH 7 phosphate buffer by UV-vis spectrophotometric analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to SOX2 promoter 5'-CTTTGTT-3' DNA in mouse Hepa1 cells assessed as reduction in SOX2 mRNA expression incubated for 48 hrs by qRT-PCR analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA (unknown origin) at 0.1 to 0.2 mM by agarose gel electrophoresis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Induction of autophagy in human DLD-1 cells assessed as vacuole formation at 7.5 uM incubated for 24 hrs in presence of Bafilomycin-A1 by phase contrast microscopic analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of EtBr from calf thymus DNA incubated for 3 mins by fluorescence based assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]DTG from sigma 2 receptor in rat PC12 cells incubated for 120 mins in presence of [3H]-(+)-pentazocine by liquid scintillation counting method","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]CP55940 from human CB1R transfected in HEK293EBNA cell membranes incubated for 90 mins by Microbeta TriLux based luminescence analysis","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Displacement of [3H]-LSD from human 5HT6 receptor expressed in HEK293 cell membrane at 10^-6 M measured after 60 mins relative to control","cats":{"Radioligand binding (BAO_0002776)":1.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to DNA Hoxa9-binding site-5'-ATTTA\/5'ATGA double mutant (strand a-CTGCGTAGCGTCACGACCGC\/strand b-GCGGTCGTGACGCTACGCAG) (unknown origin) by UV\/visible spectrophotometric method","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human MAP3K2 at 1 uM by KINOMEscan scanMAX assay relative to control","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antitumor activity against human Raji cells xenografted in NOD-SCID mouse assessed as tumor growth inhibition at 1.5 mg\/kg, po administered for 25 days","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":1.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to human recombinant 5-HT2A assessed as inhibition constant","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":1.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Agonist activity at STING in mouse RAW-Lucia ISG cells assessed as activation of ISG pathway incubated for 24 hrs by Quanti-Luc or Quanti-blue reagent based luminescence assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Downregulation of MMP9 protein expression in human HepG2 cells at 25 to 50 uM incubated for 24 hrs by Western blot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Induction of CDK9\/Cyclin T1 degradation in human 22Rv1 cells assessed as downregulation of AR-V7 splice variant protein expression at 2 uM measured after 24 hrs by immunoblot analysis","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":1.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition incubated for 5 hrs under shaking condition by resazurin dye based assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":0.0,"Antimicrobial activity":1.0}}
{"text":"Cytotoxicity against human LXFL 529 cells assessed as cell growth inhibition measured after 3 days by SRB assay","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":1.0,"Nucleic acid binding":0.0,"Antimicrobial activity":0.0}}
{"text":"Binding affinity to calf thymus DNA assessed as stabilization by measuring melting temperature at ratio of 0.2 by UV\/vis spectrophotometric (Rvb = 66 degreeC)","cats":{"Radioligand binding (BAO_0002776)":0.0,"Binding (BAO_0002989)":0.0,"Protein activity (BAO_0013016)":0.0,"in vivo method (BAO_0040021)":0.0,"Cell phenotype (BAO_0002542)":0.0,"Nucleic acid binding":1.0,"Antimicrobial activity":0.0}}
